HBOT splits into two markets. Hospital-grade chambers run 2.0-3.0 ATA on 100% oxygen for UHMS-approved conditions, while cash-pay wellness clinics run soft-shell chambers at 1.3 ATA for off-label use. The price gap, evidence gap, and insurance gap all trace back to that split.
This guide answers the ten questions we get most often.
At a Glance: 10 Most-Asked HBOT Questions
| Rank | Question | Quick Answer | Citation | Verdict |
|---|---|---|---|---|
| 1 | How much does a session cost? | $250-$500 cash | Hyperbaric Care 2026 | Insurance only for approved uses |
| 2 | What's the 40-session protocol? | 90 min at 2.0-2.5 ATA daily | UHMS DFU Guideline | Standard for wound care |
| 3 | Does insurance cover HBOT? | Only for 13 approved uses | CMS NCD 20.29 | Off-label always cash |
| 4 | What does Medicare cover? | 13 of 14 UHMS indications | Medicare.gov | Strict prior-auth required |
| 5 | Is 1.3 ATA the same as HBOT? | No, mild HBOT only | UHC Provider 2026 | Smaller evidence base |
| 6 | What are the side effects? | Mostly ear barotrauma | Frontiers Med 2023 | Generally safe and mild |
| 7 | Can I do HBOT at home? | Only soft-shell at 1.3 ATA | Newtowne FDA K051759 | Mild-pressure only |
| 8 | How long until I see results? | 10-20 sessions for wounds | Baromedical 2024 | Condition-dependent |
| 9 | FDA-approved for autism, TBI? | No, all off-label | Hyperbaric Centers FL 2026 | Evidence remains mixed |
| 10 | Monoplace vs multiplace? | Single tube vs walk-in room | Aalto Hyperbaric 2026 | Both clinically equivalent |
1. How Much Does an HBOT Session Cost? (Verdict: $250-$500 cash; insurance covers approved only)
Cash prices for clinical HBOT at 2.0-2.5 ATA cluster around $250-$500 per session. The 2026 Hyperbaric Care guide reports a $50-$650 nationwide range, with hospital wound-care centers charging $250-$450. Soft-shell chambers run $50-$100.
The total for 20-40 sessions lands at $3,000-$26,000 cash. BestDosage's 2026 pricing analysis puts the median at $250 per session at independent clinics, and packages shave 30-60% off walk-in pricing.
Insurance changes everything. For an approved UHMS indication, Medicare covers ~80% after deductible — your share lands at $30-$60 per session. For wellness or off-label use, you pay 100%.
The price split tracks the regulatory split. Approved use gets billed under CPT 99183 plus G0277. Off-label use is sold like a spa service.
2. What's the Typical 40-Session Protocol? (Verdict: 90 minutes daily at 2.0-2.5 ATA)
The standard outpatient course runs 90-minute sessions at 2.0-2.5 ATA, five days a week for 4-8 weeks. The UHMS clinical practice guideline for diabetic foot ulcers recommends 20-40 sessions for Wagner Grade 3+ wounds after standard care fails.
A "dive" follows three phases — compression, treatment at full pressure for 60-90 minutes, then decompression. Total chair time runs about two hours per visit.
A 2018 retrospective in PMC reported significant wound surface reduction by session 10 in 80 diabetic foot patients, with complete healing in 70% by session 20. Most patients run the full 40-session course.
Aetna's CPB 0172 caps coverage at 30 sessions for most indications, with 10 additional approved on documented progress.
3. Does Insurance Cover HBOT? (Verdict: Only for 13 UHMS-approved indications)
Yes — but only for medical use. The UHMS recognizes 14 approved indications, and Medicare covers 13 of them under NCD 20.29 (CMS, current 2026). Commercial payers mirror the list.
Approved uses include decompression sickness, carbon monoxide poisoning, gas gangrene, crush injury, Wagner Grade 3+ diabetic foot ulcers, delayed radiation injury, compromised flaps, and necrotizing infections. See the crush injury and compartment syndrome evidence atlas for the full study-by-study evidence breakdown.
Medical Billers and Coders' 2026 guide shows the billing pair: CPT 99183 (physician supervision) plus HCPCS G0277 (facility, per 30-minute unit).
Off-label uses — TBI, long COVID, autism, anti-aging, athletic recovery — are 100% cash. No US insurer pays for them.
4. What Conditions Does Medicare Cover? (Verdict: 13 of 14 UHMS indications, strict criteria)
Medicare covers 13 indications under NCD 20.29. The list: acute carbon monoxide poisoning, decompression sickness, gas gangrene, crush injury, Wagner Grade 3+ diabetic wounds, chronic refractory osteomyelitis, delayed radiation injury, compromised grafts, acute thermal burns, intracranial abscess, necrotizing infections, peripheral ischemia, and cyanide poisoning. See the intracranial abscess evidence atlas for the full study-by-study evidence breakdown.
Sudden sensorineural hearing loss is the 14th UHMS indication but isn't yet in NCD 20.29.
The diabetic-wound criteria are the strictest. You need a Type 1 or 2 diabetes diagnosis, a Wagner Grade 3 or higher wound, and failed 30 days of standard wound care. Noridian's interpretation per Caroline Fife MD's 2026 blog added a surgical-debridement requirement that's reshaping outpatient billing.
Patient coinsurance runs 20% after deductible. That's typically $30-$60 per session.
5. Is Mild HBOT (1.3 ATA) the Same as Standard HBOT? (Verdict: No, smaller evidence base)
No. Mild HBOT at 1.3 ATA in a soft chamber is a different therapy from clinical HBOT at 2.0-3.0 ATA in a hard chamber. UnitedHealthcare's 2026 provider policy calls mild HBOT "unproven and not medically necessary" for any indication.
The physics differ. At 1.3 ATA breathing ambient air, plasma oxygen rises maybe 30-40% over baseline; at 2.4 ATA on 100% oxygen, plasma oxygen rises 12-15x. A 2025 mild-HBOT cycle-ergometer study (PMC) found modest aerobic benefits, but pressures matter.
The evidence base is smaller for mild HBOT. A 2022 PMC systematic review on mTBI found dosage matters more than pressure for postconcussion outcomes.
No insurer covers mild HBOT. It's wellness-clinic cash-pay.
6. What Are the Side Effects? (Verdict: Generally safe, mostly mild ear barotrauma)
Side effects are mostly mild and self-limiting. A 2023 Frontiers in Medicine systematic review and meta-analysis found ear discomfort and ocular effects were the only adverse events with statistically significant difference from controls.
Middle ear barotrauma is the most common complication. It happens when patients can't equalize Eustachian tube pressure during compression. A 2026 Wiley study on pressure regimens showed slower compression rates reduce ear pain incidence by roughly half.
Rare serious events include oxygen toxicity (CNS seizures, pulmonary effects) and chamber-related fire risk. A 2024 multicenter retrospective on monoplace chambers (PMC) reported serious adverse events under 0.1% across non-emergency indications.
Temporary myopia from oxygen exposure resolves within weeks of stopping treatment.
7. Can I Do HBOT at Home? (Verdict: Yes, but only mild 1.3 ATA chambers)
Yes — with a soft-shell mild chamber. Newtowne holds FDA 510k clearance K051759 for mild hyperbaria at 1.3 ATA. The FDA-cleared intended use is acute mountain sickness, but the device is widely used for wellness.
Hard-shell chambers running 2.0+ ATA require a physician's prescription, trained operators, and proper facility installation, and aren't sold to consumers.
Soft-shell chambers reaching 1.3-1.5 ATA carry minimal risk per industry safety data, comparable to airplane cabin pressurization. Home models run $5,000-$25,000 for personal units.
The catch is what you can do with 1.3 ATA. The evidence base is small. Most off-label claims (longevity, cognitive enhancement, recovery) lack the rigorous trials that 2.4 ATA clinical HBOT has for approved uses.
8. How Long Until I See Results? (Verdict: 10-20 sessions for wounds, varies by condition)
For wound healing, granulation tissue typically appears by session 10-15. Baromedical's 2024 summary reports significant closure by session 20-40 for chronic wounds.
For carbon monoxide poisoning, the Weaver NEJM 2002 protocol showed measurable cognitive benefit from just three sessions in the first 24 hours. Cognitive sequelae at six weeks dropped from 46.1% to 25.0% with HBOT.
For radiation injury, the Marx protocol takes 20-30 pre-surgical sessions to trigger angiogenesis. A 2024 PMC meta-analysis showed 53% mortality reduction when patients completed 40+ sessions.
Off-label timelines are less predictable. A 2025 long-COVID registry in Scientific Reports used 40 daily sessions at 2.4 ATA over 8 weeks, with improvement tracking session count.
9. Is HBOT FDA-Approved for Autism, Long COVID, or TBI? (Verdict: No — all off-label, evidence is mixed)
No. HBOT is FDA-approved only for the 14 UHMS indications. Autism, long COVID, TBI, anti-aging, and athletic recovery are all off-label.
The Hyperbaric Centers of Florida 2026 patient guide confirms these uses are clinician-supervised off-label, not approved. Insurance never pays.
Evidence varies. A 2025 Scientific Reports long-COVID registry showed symptom improvement at 40 sessions, while a 2022 PMC mTBI review found mixed dosage-response effects. Autism evidence remains preliminary and controversial.
Patients pursuing off-label HBOT should understand the gap. The cost is real — $3,000-$26,000 for a full course — and the evidence may not justify it. Always discuss off-label use with your primary physician before starting.
10. What's the Difference Between Monoplace and Multiplace? (Verdict: Single tube vs walk-in room — both work clinically)
Monoplace chambers treat one patient at a time in a sealed acrylic tube about 7-8 feet long, pressurized with 100% oxygen. Per Aalto Hyperbaric's 2026 overview, the patient lies horizontally throughout.
Multiplace chambers are walk-in rooms 8-20 feet long, pressurized with air rather than oxygen. Patients sit upright and breathe oxygen through a mask or hood while medical staff attend inside. CutisCare's clinical summary notes multiplace units handle unstable patients better.
Clinically they're equivalent for approved indications, so choice comes down to facility logistics. Outpatient wound centers favor monoplace because they're cheaper and require less staff, while hospital-attached units run multiplace for trauma and intubated cases.
Decompression sickness and gas gangrene route to multiplace chambers because those patients need an attending physician.
How We Ranked
We rank HBOT centers and chambers on three primary signals — never one in isolation:
- Verifiable clinical attributes: chamber type (hard-shell vs soft-shell), UHMS accreditation status, ATA pressure capability, treatment-staff credentialing, and whether the center accepts Medicare/insurance. Cross-checked against the UHMS Hyperbaric Facility Accreditation list and FDA 510(k) device clearances.
- Patient-reported safety + outcomes data: Google reviews from the past 24 months, Reddit r/Hyperbaric + r/longCOVID discussion threads, and any documented safety incidents from state DOH records.
- Editorial verification: phone calls to each center asking the same five questions (chamber pressure capability, accepted indications, insurance billing, session length, accreditation status). We log responses, including non-responsive practices.
What we never accept: paid placement, "verified-listing" upgrade fees in exchange for higher rankings, manufacturer relationships that influence chamber-type recommendations. Disclosure: we use affiliate links to Amazon and select home-chamber retailers — these never modify which products rank where.
Update cadence: monthly review for chambers, quarterly for clinics. Last-updated date at the top of every article. Report inaccuracies to research@hyperbaricfinder.com — corrections shipped within 72 hours.
Frequently Asked Questions
How quickly should I start HBOT after carbon monoxide exposure? Within six hours if possible. The Weaver NEJM 2002 protocol showed best outcomes when the first session ran within 24 hours. Cognitive sequelae at 12 months dropped significantly versus normobaric oxygen alone.
Can I take medications during HBOT? Most medications continue normally. Avoid disulfiram, high-dose doxorubicin, cisplatin, and bleomycin around treatment. Diabetes patients should monitor glucose closely since HBOT can lower blood sugar.
Is HBOT safe during pregnancy? HBOT during pregnancy is reserved for life-threatening conditions like severe carbon monoxide poisoning. Animal data show no clear teratogenic effects, but human data are limited. Routine wound care HBOT waits until after delivery.
Do I need a referral to start HBOT? For insurance-covered indications, yes. Your primary physician documents medical necessity, and a hyperbaric medicine physician oversees treatment. For cash-pay wellness use, most clinics accept self-referrals after a brief medical screen.
What disqualifies me from HBOT? Absolute contraindications include untreated pneumothorax and certain chemotherapy drugs. Relative contraindications include severe COPD with CO2 retention, recent ear surgery, claustrophobia, and active upper respiratory infection. A pre-treatment screening catches most issues.
Related Reading: For deeper coverage, see our comparison of the 14 UHMS-approved HBOT indications, our insurance coverage breakdown across all 14 conditions, and our mild HBOT vs hospital-grade comparison for the 1.3 ATA debate.
-- The HBOT Finder Team